Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.

Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, Asaad R, Heinzel FP, Tary-Lehmann M, Lederman MM, Anthony DD.

J Virol. 2009 Nov;83(21):11175-87. doi: 10.1128/JVI.00753-09. Epub 2009 Aug 19.

2.

Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.

Yonkers NL, Milkovich KA, Rodriguez B, Post AB, Asaad R, Heinzel FP, Valdez H, Tary-Lehmann M, Anthony DD.

Clin Immunol. 2009 May;131(2):288-97. doi: 10.1016/j.clim.2008.12.012. Epub 2009 Feb 3.

3.
4.

CpG-induced IFNgamma expands TLR4-specific IL-18 responses in vivo.

Gupta S, Gould MP, DeVecchio J, Canaday DH, Auletta JJ, Heinzel FP.

Cell Immunol. 2006 Oct;243(2):75-82. Epub 2007 Feb 9.

5.

In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and type II IFN.

Greene JA, DeVecchio JL, Gould MP, Auletta JJ, Heinzel FP.

J Immunol. 2006 May 15;176(10):5995-6003.

6.

Fms-like tyrosine kinase 3-based immunoprophylaxis against infection is improved by adjuvant treatment with anti-interleukin-10 antibody.

Das L, DeVecchio J, Heinzel FP.

J Infect Dis. 2005 Aug 15;192(4):693-702. Epub 2005 Jul 14.

PMID:
16028140
7.

Interleukin 12 and interferon-gamma synthetic deficiency is associated with dendritic cell cytopenia after cardiac surgery.

Yadavalli GK, Chien JW, Wener KM, Devecchio JL, Gupta S, Salata RA, Lee JH, Caldeira C, Auletta JJ, Heinzel FP.

Shock. 2005 Jul;24(1):26-33.

PMID:
15988317
8.

Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation.

Johnson AC, Heinzel FP, Diaconu E, Sun Y, Hise AG, Golenbock D, Lass JH, Pearlman E.

Invest Ophthalmol Vis Sci. 2005 Feb;46(2):589-95.

PMID:
15671286
9.

Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation.

Auletta JJ, Devecchio JL, Ferrara JL, Heinzel FP.

Biol Blood Marrow Transplant. 2004 Dec;10(12):834-47.

10.

Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection.

Anthony DD, Yonkers NL, Post AB, Asaad R, Heinzel FP, Lederman MM, Lehmann PV, Valdez H.

J Immunol. 2004 Apr 15;172(8):4907-16.

11.

Distinct modulatory effects of LPS and CpG on IL-18-dependent IFN-gamma synthesis.

Gould MP, Greene JA, Bhoj V, DeVecchio JL, Heinzel FP.

J Immunol. 2004 Feb 1;172(3):1754-62.

12.

Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis.

Murray HW, Lu CM, Brooks EB, Fichtl RE, DeVecchio JL, Heinzel FP.

Infect Immun. 2003 Nov;71(11):6453-62.

13.

Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.

Murray HW, Brooks EB, DeVecchio JL, Heinzel FP.

Antimicrob Agents Chemother. 2003 Aug;47(8):2513-7.

14.

Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.

Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.

J Infect Dis. 2003 Aug 1;188(3):458-64. Epub 2003 Jul 14.

PMID:
12870129
15.

Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

Garhart CA, Nedrud JG, Heinzel FP, Sigmund NE, Czinn SJ.

Infect Immun. 2003 Jun;71(6):3628-33.

17.

Regulation of endotoxin-induced keratitis by PECAM-1, MIP-2, and toll-like receptor 4.

Khatri S, Lass JH, Heinzel FP, Petroll WM, Gomez J, Diaconu E, Kalsow CM, Pearlman E.

Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2278-84.

PMID:
12091428
18.

Deactivation of the innate cellular immune response following endotoxic and surgical injury.

Yadavalli GK, Auletta JJ, Gould MP, Salata RA, Lee JH, Heinzel FP.

Exp Mol Pathol. 2001 Dec;71(3):209-21. Review.

PMID:
11733946
19.
20.
23.

Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response.

Yip HC, Karulin AY, Tary-Lehmann M, Hesse MD, Radeke H, Heeger PS, Trezza RP, Heinzel FP, Forsthuber T, Lehmann PV.

J Immunol. 1999 Apr 1;162(7):3942-9.

25.

Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis.

Sang DK, Ouma JH, John CC, Whalen CC, King CL, Mahmoud AA, Heinzel FP.

J Infect Dis. 1999 Mar;179(3):743-6.

PMID:
9952391
26.
27.
28.

In vivo production and function of IL-12 p40 homodimers.

Heinzel FP, Hujer AM, Ahmed FN, Rerko RM.

J Immunol. 1997 May 1;158(9):4381-8.

PMID:
9127002
29.

IFN-gamma-independent production of IL-12 during murine endotoxemia.

Heinzel FP, Rerko RM, Ahmed F, Hujer AM.

J Immunol. 1996 Nov 15;157(10):4521-8.

PMID:
8906830
30.

Immunoregulation of murine leishmaniasis by interleukin-12.

Heinzel FP, Ahmed F, Hujer AM, Rerko RM.

Res Immunol. 1995 Sep-Oct;146(7-8):575-81. Review.

PMID:
8839164
31.
32.

IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi.

Pearlman E, Heinzel FP, Hazlett FE Jr, Kazura JW.

J Immunol. 1995 May 1;154(9):4658-64.

PMID:
7722318
33.

Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon.

Heinzel FP, Rerko RM, Ling P, Hakimi J, Schoenhaut DS.

Infect Immun. 1994 Oct;62(10):4244-9.

34.
35.

Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis.

Wang ZE, Reiner SL, Hatam F, Heinzel FP, Bouvier J, Turck CW, Locksley RM.

J Immunol. 1993 Aug 15;151(4):2077-86.

PMID:
8102158
36.

IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.

Heinzel FP, Rerko RM, Hatam F, Locksley RM.

J Immunol. 1993 May 1;150(9):3924-31.

PMID:
8473741
37.

Recombinant interleukin 12 cures mice infected with Leishmania major.

Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK.

J Exp Med. 1993 May 1;177(5):1505-9.

38.

Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.

Holaday BJ, Sadick MD, Wang ZE, Reiner SL, Heinzel FP, Parslow TG, Locksley RM.

J Immunol. 1991 Sep 1;147(5):1653-8.

PMID:
1831830
39.

Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity.

Jendroska K, Heinzel FP, Torchia M, Stowring L, Kretzschmar HA, Kon A, Stern A, Prusiner SB, DeArmond SJ.

Neurology. 1991 Sep;41(9):1482-90.

PMID:
1679911
40.
41.

Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection.

Locksley RM, Heinzel FP, Holaday BJ, Mutha SS, Reiner SL, Sadick MD.

Res Immunol. 1991 Jan;142(1):28-32. Review. No abstract available.

PMID:
1829257
42.

The role of IFN-gamma in the pathology of experimental endotoxemia.

Heinzel FP.

J Immunol. 1990 Nov 1;145(9):2920-4.

PMID:
2120341
43.
44.

Infections in patients with humoral immunodeficiency.

Heinzel FP.

Hosp Pract (Off Ed). 1989 Sep 15;24(9):99-103, 106-111 passim. Review.

PMID:
2504754
46.

Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Locksley RM, Crowe S, Sadick MD, Heinzel FP, Gardner KD Jr, McGrath MS, Mills J.

J Clin Invest. 1988 Dec;82(6):2097-105.

47.
48.
49.

Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells.

Locksley RM, Heinzel FP, Shepard HM, Agosti J, Eessalu TE, Aggarwal BB, Harlan JM.

J Immunol. 1987 Sep 15;139(6):1891-5.

PMID:
3497981
50.

Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets.

Locksley RM, Heinzel FP, Sadick MD, Holaday BJ, Gardner KD Jr.

Ann Inst Pasteur Immunol. 1987 Sep-Oct;138(5):744-9.

PMID:
2964247

Supplemental Content

Loading ...
Support Center